Descripción

Dose-response and duration analysis of PPI use in relation to cognitive outcomes suggests that cumulative exposure may modulate the strength of association with adverse neurological effects.

Figure 5

Chart

Source Paper

Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia Connection and Co-morbid Risks.

Current Alzheimer research (2024)

PMID: 38424433

DOI: 10.2174/0115672050289946240223050737

Cite This Figure

![Figure 5: Dose-response and duration analysis of PPI use in relation to cognitive outcomes suggests that cumulative exposure may modulate the strength of association with adverse neurological effects.]()

> Source: Zuber Khan et al. "Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia C." *Current Alzheimer research*, 2024. PMID: [38424433](https://pubmed.ncbi.nlm.nih.gov/38424433/)

<figure>
  <img src="" alt="Dose-response and duration analysis of PPI use in relation to cognitive outcomes suggests that cumulative exposure may modulate the strength of association with adverse neurological effects." />
  <figcaption>Figure 5. Dose-response and duration analysis of PPI use in relation to cognitive outcomes suggests that cumulative exposure may modulate the strength of association with adverse neurological effects.<br>  Source: Zuber Khan et al. "Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia C." <em>Current Alzheimer research</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38424433/">38424433</a></figcaption>
</figure>

Evidencia relacionada

Vitamin B12 para Age-Related Cognitive Decline

Calificación B · 12 estudios